Key result
Elevated cardiac troponin in acute stroke without ACS was associated with a higher rate of nonfatal myocardial infarction compared to normal troponin (41.2% vs 3.3%, P=0.0001).
Why the study?
Does elevated cardiac troponin predict nonfatal myocardial infarction and MACE in patients with acute stroke without ACS?
Population
200 patients admitted for acute stroke with measured cardiac troponin I, no evidence of acute coronary…
Comparison
Elevated cardiac troponin vs Normal cardiac troponin
Design
Cohort
Follow-up
mean 20.1 months
Authors
Loading...
Elevated troponin may warrant closer long-term CV monitoring post-stroke without ACS; leaves open whether targeted strategies improve outcomes.
Cohort (n=200)
No
Does elevated cardiac troponin predict nonfatal myocardial infarction and MACE in patients with acute stroke without ACS?
Absolute Event Rate: 41.2% vs 3.3%
p-value: p=0.0001
Elevated cardiac troponin in acute stroke patients without ACS strongly predicts long-term adverse cardiovascular outcomes, including nonfatal MI and death.
Raza et al. (2014) conducted a cohort in Acute stroke without acute coronary syndrome (n=200). Elevated cardiac troponin vs. Normal cardiac troponin was evaluated on Nonfatal myocardial infarction during follow-up period after discharge (p=0.0001). Elevated cardiac troponin in acute stroke without ACS was associated with a higher rate of nonfatal myocardial infarction compared to normal troponin (41.2% vs 3.3%, P=0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: